CN1129439C - Hyperosteogeny-treating capsule - Google Patents
Hyperosteogeny-treating capsule Download PDFInfo
- Publication number
- CN1129439C CN1129439C CN00111054A CN00111054A CN1129439C CN 1129439 C CN1129439 C CN 1129439C CN 00111054 A CN00111054 A CN 00111054A CN 00111054 A CN00111054 A CN 00111054A CN 1129439 C CN1129439 C CN 1129439C
- Authority
- CN
- China
- Prior art keywords
- radix
- hyperosteogeny
- medicine
- root
- myrrha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention discloses a medicine for treating hyperosteogeny, which takes traditional Chinese medicines as raw materials: eupolyphaga, angelica, frankincense, myrrh, garden balsam stem, silkworm, twotoothed achyranthes root, licorice root, black-tail snake, Chinese clematis, scorpion, common aucklandia root, fortune's drynaria rhizome, sanguis draconis, ephedra, ledebouriella root, swordlike atractylodes rhizome, etc. The medicine is prepared into capsules according to a certain proportion, which has treating and relieving effect on the pain caused by hyperosteogeny, and the medicine is convenient for patients to take and accept.
Description
The present invention relates to a kind of Chinese medicine preparation, a kind of specifically is the medicament capsule that is used for the treatment of hyperosteogeny of feedstock production with Chinese medicine.
Hyperosteogeny is a kind of commonly encountered diseases of orthopaedics, is because due to the degeneration of bone, often based on cervical vertebra, lumbar vertebra, knee joint, its cardinal symptom is a pain.The treatment means of doctor trained in Western medicine mostly is and adopts nonsteroidal anti-inflammatory analgetic thing (as aspirin, ibuprofen, indometacin etc.) at present, but owing to there is significantly untoward reaction, usually brings very big mental burden to the patient; Its late result still seldom arrives certainly though physical therapy and acupuncture and moxibustion therapy untoward reaction are less; Also have on the market common as " Unguentum Moschus et Os Tigris " though easy to use since some raw material (as Os Tigris) thus scarcity its curative effect is had a greatly reduced quality; Though Chinese herbs decoction can overcome above-mentioned shortcoming, the patient often is reluctant to accept because of suspicion boils " trouble ".
Purpose of the present invention aims to provide a kind of can either playing hyperosteogeny and treats preferably or relief of symptoms effect, the form of Chinese drug that the patient is taken like a shot again.
Solution of the present invention is according to understanding and the determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs principle of the traditional Chinese medical science to hyperosteogeny, according to traditional Chinese medical science prescription and the capsule preparations that processes of preparation principle.
Chinese herbal medicine of the present invention is formed (consumption is a weight portion, and the back is together) by following component:
Eupolyphaga Seu Steleophaga: 60～80; Radix Angelicae Sinensis: 30～50; Olibanum: 15～30; Myrrha: 15～30; Herba speranskiae tuberculatae: 30～50; Bombyx Batryticatus: 15～30; Radix Achyranthis Bidentatae: 15～30; Radix Glycyrrhizae: 30～50; Zaocys: 60～80; Radix Clematidis: 60～80; Scorpio: 15～30; The Radix Aucklandiae: 30～50; Rhizoma Drynariae: 30～50; Sanguis Draxonis: 60～80; Herba Ephedrae: 15～30; Radix Saposhnikoviae: 30～50; Rhizoma Atractylodis: 15～30.
Optimum ratio of the present invention is:
Eupolyphaga Seu Steleophaga: 65～75; Radix Angelicae Sinensis: 35～45; Olibanum: 18～25; Myrrha: 18～25; Herba speranskiae tuberculatae: 35～45; Bombyx Batryticatus: 18～25; Radix Achyranthis Bidentatae: 18～25; Radix Glycyrrhizae: 35～45; Zaocys: 65～75; Radix Clematidis: 65～75; Scorpio: 18～25; The Radix Aucklandiae: 35～45; Rhizoma Drynariae: 35～45; Sanguis Draxonis: 65～75; Herba Ephedrae: 18～25; Radix Saposhnikoviae: 35～45; Rhizoma Atractylodis: 18～25.
Most preferably proportioning of the present invention is:
Eupolyphaga Seu Steleophaga: 70; Radix Angelicae Sinensis: 40; Olibanum: 20; Myrrha: 20; Herba speranskiae tuberculatae: 40; Bombyx Batryticatus: 20; Radix Achyranthis Bidentatae: 20; Radix Glycyrrhizae: 40; Zaocys: 70; Radix Clematidis: 70; Scorpio: 20; The Radix Aucklandiae: 40; Rhizoma Drynariae: 40; Sanguis Draxonis: 70; Herba Ephedrae: 20; Radix Saposhnikoviae: 40; Rhizoma Atractylodis: 20.
Above medicine Radix Achyranthis Bidentatae, Herba Ephedrae, Scorpio, Bombyx Batryticatus are fried to yellow, Rhizoma Atractylodis plus wheat bran parching to brown, Olibanum, Myrrha are gone into clean deoiling in the earthen basin, place again and fry in the earthen basin, be smalls altogether after adding other component, incapsulate to basic non-foam, every capsules weighs 0.5 gram, obey every day three times, obey 2～4 balls at every turn, 30 days is a course of treatment.
Each component compatibility among the present invention uses the effect that can play activating blood circulation to dissipate blood stasis, antalgic, enriching yin and nourishing kidney, thereby for hyperosteogeny cause pain the effect of treatment or relief of symptoms is arranged preferably, and the present invention does not have obvious toxic-side effects, and using method is easy, and the patient is easy to accept.
Most preferred embodiment of the present invention is as follows:
Eupolyphaga Seu Steleophaga: 70; Radix Angelicae Sinensis: 40; Olibanum: 20; Myrrha: 20; Herba speranskiae tuberculatae: 40; Bombyx Batryticatus: 20; Radix Achyranthis Bidentatae: 20; Radix Glycyrrhizae: 40; Zaocys: 70; Radix Clematidis: 70; Scorpio: 20; The Radix Aucklandiae: 40; Rhizoma Drynariae: 40; Sanguis Draxonis: 70; Herba Ephedrae: 20; Radix Saposhnikoviae: 40; Rhizoma Atractylodis: 20.
Claims (3)
1. a medicament capsule for the treatment of hyperosteogeny is made in the conventional method preparation and the conventional capsule of packing into by Chinese herbal medicine, and it is characterized in that: its Chinese herbal medicine is made up of following component according to weight portion:
Eupolyphaga Seu Steleophaga: 60～80; Radix Angelicae Sinensis: 30～50; Olibanum: 15～30; Myrrha: 15～30; Herba speranskiae tuberculatae: 30～50; Bombyx Batryticatus: 15～30; Radix Achyranthis Bidentatae: 15～30; Radix Glycyrrhizae: 30～50; Zaocys: 60～80; Radix Clematidis: 60～80; Scorpio: 15～30; The Radix Aucklandiae: 30～50; Rhizoma Drynariae: 30～50; Sanguis Draxonis: 60～80; Herba Ephedrae: 15～30; Radix Saposhnikoviae: 30～50; Rhizoma Atractylodis: 15～30.
2. the medicament capsule of treatment hyperosteogeny as claimed in claim 1 is characterized in that: Chinese herbal medicine can be taked following component according to weight portion:
Eupolyphaga Seu Steleophaga: 65～75; Radix Angelicae Sinensis: 35～45; Olibanum: 18～25; Myrrha: 18～25; Herba speranskiae tuberculatae: 35～45; Bombyx Batryticatus: 18～25; Radix Achyranthis Bidentatae: 18～25; Radix Glycyrrhizae: 35～45; Zaocys: 65～75; Radix Clematidis: 65～75; Scorpio: 18～25; The Radix Aucklandiae: 35～45; Rhizoma Drynariae: 35～45; Sanguis Draxonis: 65～75; Herba Ephedrae: 18～25; Radix Saposhnikoviae: 35～45; Rhizoma Atractylodis: 18～25.
3. the medicament capsule of treatment hyperosteogeny as claimed in claim 1 is characterized in that: Chinese herbal medicine can be taked following component according to weight portion:
Eupolyphaga Seu Steleophaga: 70; Radix Angelicae Sinensis: 40; Olibanum: 20; Myrrha: 20; Herba speranskiae tuberculatae: 40; Bombyx Batryticatus: 20; Radix Achyranthis Bidentatae: 20; Radix Glycyrrhizae: 40; Zaocys: 70; Radix Clematidis: 70; Scorpio: 20; The Radix Aucklandiae: 40; Rhizoma Drynariae: 40; Sanguis Draxonis: 70; Herba Ephedrae: 20; Radix Saposhnikoviae: 40; Rhizoma Atractylodis: 20.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00111054A CN1129439C (en) | 2000-05-22 | 2000-05-22 | Hyperosteogeny-treating capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00111054A CN1129439C (en) | 2000-05-22 | 2000-05-22 | Hyperosteogeny-treating capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1324633A CN1324633A (en) | 2001-12-05 |
| CN1129439C true CN1129439C (en) | 2003-12-03 |
Family
ID=4580996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN00111054A Expired - Fee Related CN1129439C (en) | 2000-05-22 | 2000-05-22 | Hyperosteogeny-treating capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1129439C (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100350938C (en) * | 2002-04-02 | 2007-11-28 | 张宏仁 | Traditional Chinese herbal medicine preparation for curing hyperosteogeny |
| CN100372551C (en) * | 2006-05-25 | 2008-03-05 | 范凤月 | Chinese medicine for treating hyperosteogeny |
| CN104367741A (en) * | 2014-11-10 | 2015-02-25 | 魏国 | Traditional Chinese medicine composition for treating hyperostosis |
| CN104324220A (en) * | 2014-11-24 | 2015-02-04 | 吴玲 | Traditional Chinese medicine for treating hyperostosis |
| CN105168961A (en) * | 2015-10-08 | 2015-12-23 | 淄博齐鼎立专利信息咨询有限公司 | Pharmaceutic preparation for treating hyperosteogeny |
-
2000
- 2000-05-22 CN CN00111054A patent/CN1129439C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1324633A (en) | 2001-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178894B (en) | Plaster and preparation method of plaster | |
| CN101095845A (en) | Century health preserving magical wine | |
| CN101015651A (en) | Medicine for treating protrusion of lumbar intervertebral disc | |
| CN101810685A (en) | Chinese medicinal composition for treating gonitis and preparation method thereof | |
| CN101032580B (en) | Medicine for treating rheumatic diseases | |
| CN102247497A (en) | Chinese patent medicine for treating rheumatoid arthritis | |
| CN101897879B (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
| CN101112537A (en) | Chinese traditional medicine preparations for treating hyperosteogeny disease | |
| CN1129439C (en) | Hyperosteogeny-treating capsule | |
| CN104000890B (en) | Traditional Chinese medicine for harmonizing liver and spleen, dispelling wind and eliminating dampness and nourishing blood and stopping throat pains | |
| CN101112498B (en) | Chinese traditional medicine having functions of promoting blood circulation, relaxing vein and strengthening muscles and bones and method for preparing the same | |
| CN103735647A (en) | Medicated wine for treating chronic infectious arthritis | |
| CN102579672A (en) | Medicament for treating bone hyperplasia and lumbar disc herniation | |
| CN102370688A (en) | Compound Chinese medicinal preparation for treating hyperosteogeny and preparation method thereof | |
| CN102406870A (en) | Medicament for treating rheumatic arthralgia | |
| CN101284087B (en) | Medicinal composition for curing lumbar disease | |
| CN101940656A (en) | Medicament for treating hyperosteogeny | |
| CN101703716A (en) | Chinese medicinal preparation for treating polyneuritis | |
| CN105343675A (en) | Traditional Chinese medicine preparation for treating adiposis and preparation method thereof | |
| CN104800610A (en) | Traditional Chinese medicine preparation for treating Parkinson's disease and preparation method thereof | |
| CN100402077C (en) | Medicinal composition for treating hyperosteogency | |
| CN103623268B (en) | Reconstruction pill for neurological rehabilitation and preparation method thereof | |
| CN110251645A (en) | A kind of logical prevention and treatment athlete's foot medical fluid of Chinese medicine blood vessel | |
| CN102028810B (en) | Traditional Chinese medicine for treating lumbar intervertebral disc protrusion | |
| CN102335304B (en) | Chinese medicine composition for dispelling wind, removing dampness, invigorating blood circulation, and relieving pain and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20031203 |